Accelerate Diagnostics (STU:1A80) Dividends per Share : €0.00 (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics Dividends per Share?

Accelerate Diagnostics's dividends per share for the three months ended in Sep. 2024 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, Accelerate Diagnostics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Accelerate Diagnostics Dividends per Share Historical Data

The historical data trend for Accelerate Diagnostics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Dividends per Share Chart

Accelerate Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Accelerate Diagnostics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Accelerate Diagnostics's Dividends per Share

For the Medical Devices subindustry, Accelerate Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerate Diagnostics's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Dividend Yield % falls into.

Accelerate Diagnostics Dividends per Share Calculation

Dividends paid to per common share.

Accelerate Diagnostics (STU:1A80) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Accelerate Diagnostics's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2024 )	/	EPS without NRI (Q: Sep. 2024 )
	=	0	/	-0.551
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Accelerate Diagnostics Dividends per Share Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerate Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

AXDX:USA 0H8E:UK 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics Headlines

No Headlines